# Amide Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amide-technologies

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.amidetech.com/
- Total disclosed funding: $17M
- Latest round: Series A (Jul 1, 2023)
- Investors on record: 3

## About

Founded in 2016 and based in Massachusetts, US, Amide Technologies, Inc., operates as a biotechnology company that develops technologies to improve the manufacturing process of complex peptides. In December 2023, Amide Technologies, Inc. raised USD 7.5 million in series A funding led by Little Engine Ventures, with participation from Forcefield Ventures. As of 2023, the company is led by its CEO, Mark Simon.

The company offers an automated fast-flow peptide synthesizer uses heat and flow to allow for the quick and efficient synthesis of highly hydrophobic peptides, cyclic constructs, branched peptides, and mirror image proteins.

The company’s technology enables novel modalities to provide enhanced stability against enzymatic degradation.

The company plans to use the December 2023 funding to expand its operations, develop additional instruments, and initiate new pilot programs with pharmaceutical partners.

## Funding rounds

- Series A, Jul 1, 2023, $7.5M — Little Engine Ventures, Forcefield Ventures
- Series A, Jun 1, 2023, $9M — Engine Ventures

## Investors

- Engine Ventures (https://capitalatlas.ai/funds/engine-ventures) — Series A
- Little Engine Ventures (https://capitalatlas.ai/funds/little-engine-ventures) — Series A
- Forcefield Ventures — Series A